BioGaia, a Swedish biotechnology company that develops, markets and sells probiotic products, and Nestlé have signed agreements to extend the collaboration in the field of infant nutrition products.

Researchers at BioGaia have published new scientific findings in the journal Food and Bioprocess Technology, demonstrating that BioGaia's patented LongevityGuard® technology significantly improves the ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An ...

BioGaia AB (NASDAQ: BIOG) has signed a renewed distribution agreement with Ewopharma. The extended agreement reinforces the companies' successful collaboration to date and reflects a shared ambition ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioGaia ...

As global markets exhibit mixed signals with some regions showing resilience and others facing downturns, Sweden's market remains a point of interest for investors looking for stability and growth in ...

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Prior to the new review seven meta-analyses, evaluating different probiotics as well as non-probiotic treatments, have come to the same conclusion; that L.

BioGaia reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and strategic product launches. Sales for the quarter rose by 23% to SEK 365 million, while ...

Earnings call BioGaia reported Q3 2025 sales of SEK 327M, up 7% YoY (14% organic). EBIT more than doubled to SEK 86M, with margin rising to 26% from 14%. Growth was led by U.S. and Asia Pacific, while ...

Swedish probiotic biotech company BioGaia is making headway in its short-term mission to attain profitability, reporting a 39 percent increase in sales to SEK 16.4 million for 3Q 2005. Operating ...